Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.24
-0.04 (-3.13%)
Dec 29, 2023, 4:00 PM EST - Market closed
Akebia Therapeutics Stock Forecast
Stock Price Forecast
According to 3 stock analysts, the average 12-month stock price forecast for AKBA stock stock is $4.33, which predicts an increase of 249.19%. The lowest target is $4.00 and the highest is $5.00. On average, analysts rate AKBA stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 29, 2023.
Analyst Ratings
The average analyst rating for AKBA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +222.58% | Nov 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $5 | Strong Buy | Maintains | $4 → $5 | +303.23% | Nov 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +202.42% | Sep 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $2 → $4 | Hold → Strong Buy | Upgrades | $2 → $4 | +202.42% | Aug 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +61.29% | Aug 11, 2023 |
Financial Forecast
Revenue This Year
197.69M
from 292.48M
Decreased by -32.41%
Revenue Next Year
196.50M
from 197.69M
Decreased by -0.60%
EPS This Year
-0.32
from -0.52
EPS Next Year
-0.29
from -0.32
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 206.1M | 204.7M | 270.2M | 252.5M | 404.7M | 629.8M |
| Avg | 197.7M | 196.5M | 193.3M | 238.5M | 327.3M | 441.8M |
| Low | 187.9M | 184.4M | 121.4M | 222.6M | 251.3M | 261.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -29.6% | 3.5% | 37.5% | 30.6% | 69.7% | 92.4% |
| Avg | -32.4% | -0.6% | -1.6% | 23.4% | 37.3% | 35.0% |
| Low | -35.8% | -6.7% | -38.2% | 15.2% | 5.4% | -20.2% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -0.30 | -0.26 | 0.26 | 0.56 | 0.62 | 1.70 |
| Avg | -0.32 | -0.29 | -0.05 | 0.23 | 0.59 | 1.16 |
| Low | -0.34 | -0.32 | -0.46 | -0.07 | 0.55 | 0.65 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 164.1% | 190.0% |
| Avg | - | - | - | - | 150.0% | 98.3% |
| Low | - | - | - | - | 133.9% | 10.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.